Type I IFN controls chikungunya virus via its action on nonhematopoietic cells
暂无分享,去创建一个
Alain Michault | Matthew L. Albert | J. Tschopp | S. Higgs | M. Colonna | M. Albert | O. Schwartz | Nicolas Gangneux | F. Chrétien | F. Arenzana‐Seisdedos | A. Michault | Marc Lecuit | T. Couderc | F. Guivel-Benhassine | L. Peduto | Marc Lecuit | Clémentine Schilte | Thérèse Couderc | Fabrice Chretien | Marion Sourisseau | Nicolas Gangneux | Florence Guivel-Benhassine | Anton Kraxner | Jürg Tschopp | Stephen Higgs | Fernando Arenzana-Seisdedos | Marco Colonna | Lucie Peduto | Olivier Schwartz | M. Sourisseau | C. Schilte | A. Kraxner
[1] R. Friedman. Role of Interferon in Viral Interference , 1964, Nature.
[2] F. Nazé,et al. Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus. , 2007, Clinical chemistry.
[3] Kaoru Tominaga,et al. Activation of innate immune antiviral response by NOD2 , 2009, Nature Immunology.
[4] R. Watson. Europe witnesses first local transmission of chikungunya fever in Italy. , 2007, BMJ.
[5] Kevin A. Robertson,et al. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection. , 2004, Vaccine.
[6] H. Tolou,et al. Chikungunya, l'épidémie que l'on n'attendait pas , 2006 .
[7] Michael G. Katze,et al. Establishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1 , 2007, Journal of Virology.
[8] V. ter meulen,et al. Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling , 2002, Journal of Virology.
[9] P. Perrin,et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. , 2005, Immunity.
[10] S. Ross,et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[12] S. Higgs,et al. Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes. , 2005, Insect biochemistry and molecular biology.
[13] A. Kohl,et al. PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response , 2009, The Journal of general virology.
[14] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[15] T. Dermody,et al. Peyer's Patch Dendritic Cells Process Viral Antigen from Apoptotic Epithelial Cells in the Intestine of Reovirus-infected Mice , 2004, The Journal of experimental medicine.
[16] W. Klimstra,et al. Host responses to alphavirus infection , 2008, Immunological reviews.
[17] R. Flavell,et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.
[18] L. Figueiredo,et al. Most alphaviruses share a conserved epitopic region on their nucleocapsid protein. , 1989, The Journal of general virology.
[19] S. Akira,et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. , 2004, Immunity.
[20] R. Johnston,et al. Role of Dendritic Cell Targeting in Venezuelan Equine Encephalitis Virus Pathogenesis , 2000, Journal of Virology.
[21] Akiko Iwasaki,et al. Inflammasome recognition of influenza virus is essential for adaptive immune responses , 2009, The Journal of experimental medicine.
[22] D. Mavalankar,et al. Chikungunya epidemic in India: a major public-health disaster. , 2007, The Lancet. Infectious diseases.
[23] G. Mcinerney,et al. Early Alpha/Beta Interferon Production by Myeloid Dendritic Cells in Response to UV-Inactivated Virus Requires Viral Entry and Interferon Regulatory Factor 3 but Not MyD88 , 2005, Journal of Virology.
[24] H. Klocker,et al. Prostaglandin E2 and Tumor Necrosis Factor ␣ Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production , 1997 .
[25] P. Feng,et al. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. , 1997, Science.
[26] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[27] R. Steinman,et al. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. , 1996, Journal of immunological methods.
[28] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[29] Scott R. Presnell,et al. IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.
[30] R. Medzhitov,et al. Type I interferons in host defense. , 2006, Immunity.
[31] G. Schuler,et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. , 1997, Advances in experimental medicine and biology.
[32] D. Golenbock,et al. Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2 , 2003, Journal of Virology.
[33] A. Klöti,et al. Human MxA Protein Confers Resistance to Semliki Forest Virus and Inhibits the Amplification of a Semliki Forest Virus-Based Replicon in the Absence of Viral Structural Proteins , 1998, Journal of Virology.
[34] K. Choo,et al. IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity , 2009, PloS one.
[35] Frank Kunst,et al. Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak , 2006, PLoS medicine.
[36] S. Higgs,et al. Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosqutioes , 2005 .
[37] D. E. Carey,et al. The 1964 chikungunya epidemic at Vellore, South India, including observations on concurrent dengue. , 1969, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[38] C. Havenar-Daughton,et al. Cutting Edge: The Direct Action of Type I IFN on CD4 T Cells Is Critical for Sustaining Clonal Expansion in Response to a Viral but Not a Bacterial Infection1 , 2006, The Journal of Immunology.
[39] R. Wagner. Inhibition of Interferon Biosynthesis by Actinomycin D , 1964, Nature.
[40] D. Niederwieser,et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. , 1996, Journal of immunological methods.
[41] Martin F. Bachmann,et al. Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection , 2005, Journal of Virology.
[42] J. H. Strauss,et al. The Alphaviruses: Gene Expression, Replication, and Evolution , 1994, Microbiological reviews.
[43] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[44] J. Renauld,et al. Characterization of the Murine Alpha Interferon Gene Family , 2004, Journal of Virology.
[45] Persephone Borrow,et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.
[46] Fabrice Chrétien,et al. A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease , 2008, PLoS pathogens.
[47] P. Jeandel,et al. [The unexpected Chikungunya outbreak]. , 2006, La Revue de medecine interne.
[48] A. Flahault,et al. Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: Two methods for two critical times of the epidemic , 2008, BMC infectious diseases.
[49] K. Knobeloch,et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses , 2007, Proceedings of the National Academy of Sciences.
[50] Alain Michault,et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] M. Heise,et al. Differential Induction of Type I Interferon Responses in Myeloid Dendritic Cells by Mosquito and Mammalian-Cell-Derived Alphaviruses , 2006, Journal of Virology.
[52] B. Genton,et al. Chikungunya: an epidemic in real time , 2006, The Lancet.
[53] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[54] M. Prevost,et al. Characterization of Reemerging Chikungunya Virus , 2007, PLoS pathogens.
[55] J. Mascola,et al. Human skin Langerhans cells are targets of dengue virus infection , 2000, Nature Medicine.
[56] Douglas T. Golenbock,et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.
[57] R. Rhoads,et al. Sindbis Virus Translation Is Inhibited by a PKR/RNase L-Independent Effector Induced by Alpha/Beta Interferon Priming of Dendritic Cells , 2005, Journal of Virology.
[58] R. Watson. Chikungunya fever is transmitted locally in Europe for first time , 2007, BMJ : British Medical Journal.
[59] C. Johansson,et al. Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus , 2007, The Journal of experimental medicine.
[60] R. Salomon,et al. Dendritic Cell Responses to Early Murine Cytomegalovirus Infection , 2003, The Journal of experimental medicine.
[61] Pamela J. Glass,et al. Eastern and Venezuelan Equine Encephalitis Viruses Differ in Their Ability To Infect Dendritic Cells and Macrophages: Impact of Altered Cell Tropism on Pathogenesis , 2008, Journal of Virology.